NO931040L - Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav - Google Patents
Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse deravInfo
- Publication number
- NO931040L NO931040L NO93931040A NO931040A NO931040L NO 931040 L NO931040 L NO 931040L NO 93931040 A NO93931040 A NO 93931040A NO 931040 A NO931040 A NO 931040A NO 931040 L NO931040 L NO 931040L
- Authority
- NO
- Norway
- Prior art keywords
- indoles
- preparing
- procedure
- indazol
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6532392 | 1992-03-23 | ||
| JP915693 | 1993-01-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO931040D0 NO931040D0 (no) | 1993-03-23 |
| NO931040L true NO931040L (no) | 1993-09-24 |
Family
ID=26343823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO93931040A NO931040L (no) | 1992-03-23 | 1993-03-23 | Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0562832A1 (pl) |
| KR (1) | KR930019661A (pl) |
| CN (1) | CN1081676A (pl) |
| AU (1) | AU3537893A (pl) |
| CA (1) | CA2092112A1 (pl) |
| CZ (1) | CZ47393A3 (pl) |
| FI (1) | FI931291A (pl) |
| HU (1) | HU9300828D0 (pl) |
| IL (1) | IL105139A0 (pl) |
| NO (1) | NO931040L (pl) |
| TW (1) | TW226019B (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW263504B (pl) * | 1991-10-03 | 1995-11-21 | Pfizer | |
| IT1271352B (it) * | 1993-04-08 | 1997-05-27 | Boehringer Ingelheim Italia | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale |
| GB9310582D0 (en) * | 1993-05-22 | 1993-07-07 | Smithkline Beecham Plc | Pharmaceuticals |
| US5620973A (en) * | 1993-11-30 | 1997-04-15 | Takeda Chemical Industries, Ltd. | Tetracyclic condensed heterocyclic compounds and their use |
| ES2098186B1 (es) * | 1995-02-09 | 1998-02-01 | Consejo Superior Investigacion | Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer. |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| WO1998046590A1 (en) * | 1997-04-17 | 1998-10-22 | Takeda Chemical Industries, Ltd. | Thermogenic composition and benzazepine thermogenics |
| KR100648869B1 (ko) | 1998-09-30 | 2007-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 방광 배출력 개선제 |
| CN1317276C (zh) * | 2000-09-29 | 2007-05-23 | 中国科学院上海药物研究所 | 一类吲哚基哌啶类化合物及其制备方法和用途 |
| AU2002367425B2 (en) * | 2001-12-28 | 2006-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for urinary disturbance |
| TW200621237A (en) | 2004-11-01 | 2006-07-01 | Wyeth Corp | [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones |
| DK1828182T3 (da) | 2004-11-29 | 2010-05-10 | Warner Lambert Co | Terapeutiske pyrazol[3,4-B]pyridiner og indazoler |
| US7645752B2 (en) | 2006-01-13 | 2010-01-12 | Wyeth Llc | Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors |
| MX336731B (es) | 2010-01-28 | 2016-01-28 | Harvard College | Composiciones y metodos para potenciar la actividad de proteasoma. |
| WO2011143430A1 (en) | 2010-05-12 | 2011-11-17 | Abbott Laboratories | Indazole inhibitors of kinase |
| US9556166B2 (en) | 2011-05-12 | 2017-01-31 | Proteostasis Therapeutics, Inc. | Proteostasis regulators |
| WO2014116228A1 (en) | 2013-01-25 | 2014-07-31 | President And Fellows Of Harvard College | Usp14 inhibitors for treating or preventing viral infections |
| WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2334358A1 (fr) * | 1975-12-12 | 1977-07-08 | Sogeras | Nouveaux medicaments derives de l'indole |
| FR2477544A1 (fr) * | 1980-03-07 | 1981-09-11 | Pharmindustrie | Nouveaux derives de la chloro-3 quinoleine, procedes pour leur preparation, et leur utilisation comme medicaments |
-
1993
- 1993-03-22 CA CA002092112A patent/CA2092112A1/en not_active Abandoned
- 1993-03-22 TW TW082102226A patent/TW226019B/zh active
- 1993-03-23 CZ CZ93473A patent/CZ47393A3/cs unknown
- 1993-03-23 IL IL105139A patent/IL105139A0/xx unknown
- 1993-03-23 HU HU9300828A patent/HU9300828D0/hu unknown
- 1993-03-23 NO NO93931040A patent/NO931040L/no unknown
- 1993-03-23 AU AU35378/93A patent/AU3537893A/en not_active Abandoned
- 1993-03-23 CN CN93105229A patent/CN1081676A/zh active Pending
- 1993-03-23 FI FI931291A patent/FI931291A/fi not_active Application Discontinuation
- 1993-03-23 EP EP93302220A patent/EP0562832A1/en not_active Withdrawn
- 1993-03-23 KR KR1019930004542A patent/KR930019661A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI931291A0 (fi) | 1993-03-23 |
| FI931291A (fi) | 1993-09-24 |
| CN1081676A (zh) | 1994-02-09 |
| IL105139A0 (en) | 1993-07-08 |
| KR930019661A (ko) | 1993-10-18 |
| CZ47393A3 (en) | 1993-11-17 |
| NO931040D0 (no) | 1993-03-23 |
| TW226019B (pl) | 1994-07-01 |
| AU3537893A (en) | 1993-09-30 |
| HU9300828D0 (en) | 1993-06-28 |
| CA2092112A1 (en) | 1993-09-24 |
| EP0562832A1 (en) | 1993-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO931040L (no) | Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav | |
| NO923371L (no) | Framgangsmaate og anordning for etablering av sikker kommunikasjon | |
| NO892083D0 (no) | Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner. | |
| NO911020D0 (no) | Fremgangsmaate og preparat for koiontoforese. | |
| NO943031L (no) | Fremgangsmåte og system for understöttende kommunikasjon | |
| DK297089D0 (da) | Pyrimidinderivater og fremgangsmaade til fremstilling deraf | |
| NO932662D0 (no) | Fremgangsmaate for fremstilling av kitin og kitosan av biomedisinsk kvalitet | |
| IS4244A (is) | Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra | |
| NO891866L (no) | Kromanderivater og fremgangsmaate for fremstilling derav. | |
| DK0635004T3 (da) | 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf | |
| IS4907A (is) | Nýjar bensímídasólafleiður sem vinna gegn magasári, aðferðir til að útbúa þær og lyfjablöndur sem innihalda þær | |
| DK69989A (da) | Benzodioxolderivater og fremgangsmaade til fremstilling deraf | |
| NO892494L (no) | Kromanderivater og fremgangsmaate for fremstilling derav. | |
| DK1693A (da) | Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf | |
| NO894103L (no) | Kromanderivater og fremgangsmaate for fremstilling derav. | |
| DK530689D0 (da) | Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse | |
| DK0701554T3 (da) | Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse | |
| NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
| NO930796D0 (no) | Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse | |
| DK103889D0 (da) | Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf | |
| NO934227D0 (no) | Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse | |
| NO891630D0 (no) | Fremgangsmaate og anordning for fremstilling av diafragmer. | |
| DK291188D0 (da) | 5-methoxyalkylammonium-tetrahydrofuran- og -tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater | |
| NO893963L (no) | 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav. | |
| DK0794184T3 (da) | 6-Methoxy-1H-benzotriazol-5-carboxamidderivater, fremgangsmåde til fremstilling deraf og lægemidler indeholdende dem |